chrisvoncsefalvay/vaers-outcomes huggingface dataset:
32 y/o with no medical history who present with feeling of blood rushing out of her body, feeling of going to pass out post vaccination. Patient states that this is the second vaccination in the two-dose Pfizer series. Patient denies reaction to first vaccination Patient states that vaccination was placed to the L arm. Patient denies headache, sore throat, difficulty breathing, shortness of breath, chest pain or rash. Patient placed in wheelchair and taken to partitioned area. NP and Paramedics at patient bedside. Patient placed in Trendelenburg position. Patient vitals within normal limits (124/85 BP, 65 HR, 100% RA, 12 Resp). Patient reported that feeling would come and go, described as blood leaving body. Patient states that has been on low carb diet for two months and only ate a beef patty today, chips and one bottle of water. Patient states ate two hours ago. Patient glucose obtained at this time, 89, normal. Patient EKG normal (Sinus Brady). Patient provided with protein bar and a bottle of water. Patient placed in a sitting position to eat protein bar. Patient states that after eating protein bar felt a lot better and feels that lack of eating and low carb diet contributed to symptoms. Patient was able to ambulate without difficulty. Patient discharged in stable condition with normal vitals ( 132/86 BP, 73 HR, 99% RA, 12 Resp).
This is a spontaneous report from a contactable consumer. A 55-year-old female patient received bnt162b2 (BNT162B2), via an unspecified route of administration, administered in left arm at the age of 55 years old on 11Feb2021 11:00 (Batch/Lot Number: EN6201) as dose 2, single for covid-19 immunisation. The patient had no medical history. Concomitant medications were not reported. The patient previously took first dose of bnt162b2 (lot number: EK9231) on 21Jan2021 at 11:00 AM administered at left arm for COVID-19 Immunization. No reaction reported. The patient also took amoxicillin and experienced allergies. On 28Jun2021, the patient experienced pericarditis and it was a possible diagnosis at an ER visit that ruled out any life-threatening events. SED rate test with value of 75 confirmed pericarditis on 22Jul2021. Echocardiogram, EKG, electrocardiogram, chest XR were done and all indicate healthy heart. Prednisone was prescribed after 22Jul2021. The outcome of the event was not recovered.  Follow-up attempts are completed. No further information is expected.
No additional adverse effect reported; lots that underwent temperature excursions were admnistered; This spontaneous report was received from a registered nurse, concerning a patient of unknown age and gender. No information was provided regarding the patient's pertinent medical history, concomitant medications, and previous drug reactions or allergies.  On 03-AUG-2021, the patient was vaccinated with an improperly stored dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) recombinant human albumin (rHA) (lot # T016990, which was verified to be a valid lot number, expiration date reported as 11-NOV-2021), for prophylaxis (dose, frequency, route of administration, anatomical location and vaccination scheme were not reported) (product storage error). The administered vaccine experienced a temperature excursion of 14 degrees Fahrenheit to 46 degrees Fahrenheit (24.8 degrees Fahrenheit) during a time frame of 30 minutes.   There were a previous temperature excursions n an unknown date: 6 to 14 degrees Fahrenheit (5.9 degrees Fahrenheit) during a time frame of 8 minutes, 6 to 14 degrees Fahrenheit (6.8 degrees Fahrenheit) during a time frame of 18 minutes and 6 to 14 degrees Fahrenheit (8.4 degrees Fahrenheit) during a time frame of 17 minutes.  No additional adverse events were reported.  This is one of ten reports received from the same reporter.; Sender's Comments:  US-009507513-2108USA001125:AM US-009507513-2108USA001040:AL
mom states on 24APR94 pt had sz; mom said she picked pt up & pt shook; no illness @ that time no fever p/vax; MD felt pt should receive DT; mom concerned that pt isn't hearing properly;
On left feet under knee and up swelling vain, red and hard when I touch, really painful.  Looks for me like thrombosis
Information was received from a consumer concerning her 66 year old mother with allergy to unspecified antibiotic eye drop. On 21-OCT-2013, the patient was vaccinated with ZOSTAVAX. On-22-OCT-2013, 2 days after onset of therapy the patient experienced an injection site reaction which was  "little itchy" and started out 3 inches in size and then became 5 inches in size, and was in the shape of an oval. On 26-OCT-2013 it was reported the injection site reaction resolved. Additional information has been requested.
chest pain starting at 7:30 AM, not relieved by Tylenol. Went to pediatrician office where EKG showed ST elevations in II, III, aVF. On arrival to ED EKG findings more consistent with pericarditis.
Syncope/confusion, generalized weakness, some truncal ataxia, & possible aphasia. No clear evidence of acute cardiac etiology, nor witnessed tonic-clonic motor activity.  11/05/09 Medical records recieved for DOS 11/02/09.   Nurse working in Ed became pale and dizzy and about to faint. Helped to wheelchair. Syncope followed by confusion, decreased responsiveness, lightheaded, dizziness. Mild aphasia, fluctuating LOC. Mild truncal ataxia, limb tremor, DTR knees +2/4. H/o pontine lesion.  Flu vaccine day before.    11/17 and 11/18 Medical Records received. DOS 11/02-11/03. Final Dx: Syncope, encephalopathy, acute migraine C/O feeling dizzy, passing out. S/p 1 day vaccine. History as above.
All Hospital Problems (Other Diagnoses): Active Hospital Problems   Diagnosis o Principal Problem: Syncope o Orthostatic hypotension o Chronic combined systolic and diastolic congestive heart failure (CMS/HCC) o Atrial fibrillation (CMS/HCC) o History of prostate cancer o History of lung cancer o Gastroesophageal reflux disease without esophagitis o Hx of CABG o CAD (coronary artery disease) o Primary hypertension
pt recvd vax; devel inject site rxn characterized by a swollen,warm & "lacy looking" red rash 6cm by 4cm in area;tx w/ dph & ice packs;
Pt fell asleep and lethargic after vaccination and developed cough and runny nose. He did not sleep because of a bad  cough attack and a lot of runny nose. The next day his cough got better and then got worst again, developed a fever 2nd night of 101. Administered Tylenol. Pt gurgling during the night while he slept. No previous snoring issues.
Patient was administered 0.1 ml of pfizer covid vaccine transdermal in the right forearm instead of the PPD applisol. Patient has previously been vaccinated with 2 doses of the pfizer vaccine.
Sore arm; Rash; Fever; Chills; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Sore arm), RASH (Rash), PYREXIA (Fever) and CHILLS (Chills) in a 56-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history reported.  Concomitant products included DUPILUMAB (DUPIXENT) for an unknown indication.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (Sore arm), RASH (Rash), PYREXIA (Fever) and CHILLS (Chills). At the time of the report, VACCINATION SITE PAIN (Sore arm), PYREXIA (Fever) and CHILLS (Chills) outcome was unknown and RASH (Rash) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Patient had missed 2-3 weeks of Dupilumab doses over 1-month ego.  Patient reported the onset of event as May 2021.  For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.  Treatment medication was not provided
48-hours after second vaccination, papular rash formed on right forearm (along ulnar nerve distribution). Diagnosed and treated as shingles. One week after, I developed a diffuse rash and hives all over my body (including eyelids) requiring IV steroids and diphenhydramine.
Entire injected arm swollen and red to the elbow.  Called the Doctor to report.  Swelling got worse through 5/29/2013.  Felt some stinging in arm and body aches, cough, slight fever, headache. Went to bed that night and experienced coldness to the bone.  I couldn't get warm.  I had use a heating pad all over the body.  Through the night my legs and arms felt so strange!  The only way I could get relief was to stretch my limbs for as long as possible.  It was horrible!  I couldn't get comfortable at all.  Woke up and the swelling of the arm was down and the redness not as bad.  It was like it came to a peak and then I sweated it out.  Won't get this shot again.
Soreness at left arm injection site on  day 2. Day three Body ackes runny nose.Day 4 joint  pain full flu like symtems,kidney pain,headake,coughing sore throat. These symtems continued for days 4 ,5,6,7. on day 8 all symtems were gone except for stuffed up nose that continues today But not as bad as days 4,5,6,7,
Tasted metal or a metallic taste in mouth; This is a spontaneous report from a non-contactable consumer, the patient. A 35-year-old male patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6203) via an unspecified route of administration in the left arm on 26Feb2021 at 14:30 (at the age of 35-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Concomitant medications were not reported. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EM9809) via an unspecified route of administration in the left arm on 05Feb2021 at 17:30 (at the age of 35-years-old) as a single dose for COVID-19 immunisation. On 26Feb2021 at 14:30, within 5-6 seconds after the second dose of injection, the patient tasted metal or experienced a metallic taste in the mouth. The metallic taste was strong for 2-3 days following the event. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, it was unknown whether the patient had been tested for COVID-19. Therapeutic measures were not taken as a result of the event. The clinical outcome of the event tasted metal or a metallic taste in mouth was unknown at the time of this report.  No follow-up attempts are possible. No further information is expected.
Three days after shot, it was still sore as can be, could not lift arm, nothing helped with the pain, stretching, Tylenol, heating pad, icy-hot, you name it, it didn't work. Now over five weeks later, its still the same song and dance.
10:40AM  Apprehension.  Patient stated that arm felt weak right after shot, and he's a little anxious about the vaccine.  Vitals signs:  10:45am  121/78  75  13  O2 98%;   11:00am  122/80  70  13  O2 100%;  Disposition:  After 20 minutes he felt ok going home.
Blurry vision; Arm soreness; Swollen lymph node in neck; Felt achy and sore; Itchiness on the injection site; Redness on the injection site; Headache; Severe tiredness; This spontaneous case was reported by a consumer and describes the occurrence of VISION BLURRED (Blurry vision), PAIN IN EXTREMITY (Arm soreness), LYMPHADENOPATHY (Swollen lymph node in neck), MYALGIA (Felt achy and sore) and VACCINATION SITE PRURITUS (Itchiness on the injection site) in a 76-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014F21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 08-Sep-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Sep-2021, the patient experienced VISION BLURRED (Blurry vision), PAIN IN EXTREMITY (Arm soreness), LYMPHADENOPATHY (Swollen lymph node in neck), VACCINATION SITE PRURITUS (Itchiness on the injection site), VACCINATION SITE ERYTHEMA (Redness on the injection site), HEADACHE (Headache) and FATIGUE (Severe tiredness). 09-Sep-2021, the patient experienced MYALGIA (Felt achy and sore). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency. At the time of the report, VISION BLURRED (Blurry vision), PAIN IN EXTREMITY (Arm soreness), LYMPHADENOPATHY (Swollen lymph node in neck), MYALGIA (Felt achy and sore), VACCINATION SITE PRURITUS (Itchiness on the injection site), VACCINATION SITE ERYTHEMA (Redness on the injection site), HEADACHE (Headache) and FATIGUE (Severe tiredness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No Concomitant medications were reported.
difficulty breathing; burning near the area of my heart; pain in my chest; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 17-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 21May2021 at 13:15 as dose 2, single (Batch/Lot number: unknown) at the age of 17 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "born with my stomach malrotated and received two surgerys" (unspecified if ongoing); "born with my stomach malrotated and received two surgerys" (unspecified if ongoing). The patient's concomitant medications were not reported. Vaccination history included: BNT162b2 (Dose Number: 1, Batch/Lot No: Unknown, Location of injection: Arm Left, Administration Time: 01:30 PM), administration date: 30Apr2021, when the patient was 17-year-old, for Covid-19 immunization.  The following information was reported: DYSPEPSIA (hospitalization) with onset 15Jun2021 at 14:30, outcome "not recovered", described as "burning near the area of my heart"; DYSPNOEA (hospitalization) with onset 15Jun2021 at 14:30, outcome "not recovered", described as "difficulty breathing"; CHEST PAIN (hospitalization) with onset 15Jun2021 at 14:30, outcome "not recovered", described as "pain in my chest". The events "difficulty breathing", "burning near the area of my heart" and "pain in my chest" required physician office visit and emergency room visit. Therapeutic measures were not taken as a result of dyspnoea, dyspepsia, chest pain.  Clinical course: Around the time that patient received second covid shot, began experiencing pain in chest. That was soon followed by difficulty breathing and burning near the area of heart. She originally thought it was something that would be gone in no time and the pain did fluctuate corroborating her belief, but here she was over a year later and it was affecting her day-to-day life at the time of this report. She was recently referred to a cardiologist who she hoped will be able to give the answers and treatment she deserved. If Covid prior vaccination: Unknown. Covid was not tested post vaccination. No known allergies. Lot unknown reason: Not available/provided to reporter at the time of report completion. Facility type Vaccine was other. Unknown if received other vaccine in four weeks.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Right arm could not be lifted, front, back, or up. That lasted until the following week. Still have trouble lifting anything or raising arm. Hurts right in the shoulder and sometimes to the neck. Mostly still can't move without pain. 05-FEB-2010: P. shot given high on right shoulder, still causing pain when raised to side. Painful most of time. Went to MRI fluid on bursa. 2/1/10
Per nurse giving vaccine, patient cried, held breath, then lost consciousness for few seconds. On MD arrival, pt crying and alert, vitals stable
Vaccination site rash; This spontaneous case was reported by a pharmacist and describes the occurrence of VACCINATION SITE RASH (Vaccination site rash) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history reported.     On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE RASH (Vaccination site rash). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Red rash, at a dose of 1 dosage form. At the time of the report, VACCINATION SITE RASH (Vaccination site rash) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter. Treatment medication included Benadryl. Patient developed a red splotchy rash on her skin within the 30 minute window frame of patient observation.
Injection site is itchy, feels hard, feels slightly warmer than the rest of my upper arm
Arm tightness; This spontaneous case was reported by a consumer and describes the occurrence of LIMB DISCOMFORT (Arm tightness) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination.     Concurrent medical conditions included Migraine. Concomitant products included AMLODIPINE, LOSARTAN POTASSIUM (COZARIL), ROSUVASTATIN CALCIUM (CRESTOR), OMEPRAZOLE (OPRIL [OMEPRAZOLE]), TAMSULOSIN, TOPIRAMATE (TOPAMAX), TRAZODONE and EZETIMIBE (ZETIA) for an unknown indication.    On 17-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced LIMB DISCOMFORT (Arm tightness). At the time of the report, LIMB DISCOMFORT (Arm tightness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
HIVES, REDNESS TO CHEST ARMS, FACE, ENTIRE BACK, ITCHY, HOT TO TOUCH
Patient had requested J&J vaccine, and I mistakenly administered Pfizer,  Patient was irritated they had to come back for second shot at first, but was fine about it when they left
Hives on legs and feet with difficulty breathing shortly after vaccination. Treated by EMS with 50mg benadryl, Oxygen, and 125mg solu-medrol. Sent out to ER.
Redness on the Injection Site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (Redness on the Injection Site) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 10-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Feb-2021, the patient experienced VACCINATION SITE ERYTHEMA (Redness on the Injection Site). At the time of the report, VACCINATION SITE ERYTHEMA (Redness on the Injection Site) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant medications were provided No Treatment information provided
Received call from wife that employee was "shaking like a leaf". Having some chest tightness. Instructed to seek medical attention either ED or call 911 especially if symptoms worsen with difficulty breathing or chest pain. Did go to ED and was hospitalized. Supervisor came to report patient in hospital with swelling and is presently hospitalized. Stated he did have reaction to the MMR.
Mom called 7/1/10 to report pt ran fever 104.5 - 7 hrs after vaccines. Went to ER 6/30/10 at 2:00 pm temp - 105.7. Strep test Ng. Tx steroids and antibiotic. Afebrile 7/1/10 9:30 am.
One week after the vaccine, I developed small round red, raised spots on my legs.  They occurred first 2, then a few more over the course of days--until I had approximately 6, most on my legs and thighs, but one on my forearm.  They all started the same way with the same appearance.  I felt a slight itch to them at the very first, but within 12-24 hours they flattened out and had a deep red/purple appearance. The spot that I had scratched that  most (located on my inner right thigh)  developed in to a 7 mm petechiae . I developed ITP in 1974-1975 (that resolved following a splenectomy) so I am quite familiar with the appearance of petechiae.  I may have slight easy bruising to go along with this.  It was not profound but I believe it did occur.  I was on vacation when this developed. I had my vaccine a few days before I left.  By the time I returned, October 6-7 the spots had stopped appearing.   And the bruising seemed lessened.     Most of the spots resolved within 2 weeks.  The petechiae on my thigh remains--although it is now a faint  purple disoloration, rather than a clearly a petechiae.  I have noticed now, also that this petechiae is located just above a small blood vessel.   I recently saw the doctor.  He did not do blood work as I am feeling fine with no new easy bruising.  I did not report this on vacation.
Mimic Guillain-Barre Syndrome    Severe joint pain moved systematically throughout body. Severe  muscle pain and deterioration systematically throughout body.  Lung nodules.  Severe tremors throughout body.  Attack on central nervous system. Wheel chair for two weeks. From April to current. Still have some issues.
24 hour normal vaccine reaction (fever over 101, chills, fatigue, etc). Extreme sensitivity to caffeine (no sensitivity experienced before) Shortness of breath and dizziness, feeling of constriction in chest, worst in first week after vaccine also accelerated by caffeine intake.  Symptoms lessened after stopping intake of caffeine, but are still present when exercising or stressed in third week. Seem to be lessening over time.
Had dessemination of vaccinia vaccination associated with Pedal Edeme following 2nd JAP B vaccine.
4JAN96 pt recvd vax 26OCT95 & called today requesting flu vax  info- c/o neurological problems occurring 3 wks p/vax;
hasn't had an appetite; a knot in his stomach; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A male patient received bnt162b2 (BNT162B2), administration date 16Mar2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: ABDOMINAL PAIN UPPER (non-serious) with onset 16Mar2021, outcome "unknown", described as "a knot in his stomach"; DECREASED APPETITE (non-serious), outcome "unknown", described as "hasn't had an appetite". Additional information: The patient got his first vaccination shot on the 16Mar2021, and he said the first day, he had a knot in his stomach. He hasn't had an appetite at all. The patient wanted to know if Pfizer has heard or seeing this and would like to know if that is something that is usually in like maybe a week might be seen or something.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
COVID breakthrough. Patient presented to the ED on 8/30 for reason unrelated to COVID but was tested and resulted positive. Infectious disease consult considered him asymptomatic.